rapport sur le plan d'action correctif smeta (capr)
date : 2022-01-05visites : 141

1.2021ENZAA416335562capr_SM2021CN-0199_Hunan Huacheng Biotech Inc-4P-R0_00

1.2021ENZAA416335562capr_SM2021CN-0199_Hunan Huacheng Biotech Inc-4P-R0_01

1.2021ENZAA416335562capr_SM2021CN-0199_Hunan Huacheng Biotech Inc-4P-R0_02

1.2021ENZAA416335562capr_SM2021CN-0199_Hunan Huacheng Biotech Inc-4P-R0_03

1.2021ENZAA416335562capr_SM2021CN-0199_Hunan Huacheng Biotech Inc-4P-R0_04

1.2021ENZAA416335562capr_SM2021CN-0199_Hunan Huacheng Biotech Inc-4P-R0_05

1.2021ENZAA416335562capr_SM2021CN-0199_Hunan Huacheng Biotech Inc-4P-R0_06

1.2021ENZAA416335562capr_SM2021CN-0199_Hunan Huacheng Biotech Inc-4P-R0_07

1.2021ENZAA416335562capr_SM2021CN-0199_Hunan Huacheng Biotech Inc-4P-R0_08

1.2021ENZAA416335562capr_SM2021CN-0199_Hunan Huacheng Biotech Inc-4P-R0_09

1.2021ENZAA416335562capr_SM2021CN-0199_Hunan Huacheng Biotech Inc-4P-R0_10

1.2021ENZAA416335562capr_SM2021CN-0199_Hunan Huacheng Biotech Inc-4P-R0_11

tous droits réservés : hunan huacheng biotech, inc. adallen nutrition, inc.-plan du site | politique de confidentialité | termes et conditions | blog